Back To Schedule
Monday, September 19 • 9:30am - 10:00am
Thinking Differently About Indication Prioritization: Considerations for Making Better Strategic Decisions

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

To provide participants with recommendations for how to modify current indication prioritization best practices to improve strategic decision making.
•Participants will be introduced to a new and robust framework for indication prioritization that has resulted in more balanced and actionable assessments of individual indications by focusing not only on feasibility, but also post launch differentiation and value creation
•The result of this change in approach has been improved decision making and higher corporate valuations with less risk – cases will be discussed
•Moderators from Syneos Consulting will lead the group through the following discussions:
  • -Aligning to a common definition and objectives for indication prioritization
  • -Discussing current best practices for indication prioritization and pitfalls
  • -Introducing new clinical evaluation dimensions to improve assessments of clinical feasibility
  • -Introducing TPP development and testing as an integral stage in prioritizing target indications
  • -Defining ways of working with clinical teams to ensure appropriate assumptions relating to clinical strategies and plans are developed
  • -Understanding new capabilities a company may need to build or partner to enable recommended changes

avatar for Waynne Waterfield

Waynne Waterfield

Managing Director, Commercial Advisory Group, Syneos Health
Mr. Waterfield has over 20 years of experience working as an advisor to the biopharmaceutical industry. His consulting experience spans discovery to end of life cycle, with a focus on early stage commercialization strategy development - indication prioritization, product/portfolio... Read More →

Monday September 19, 2022 9:30am - 10:00am EDT